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Abstract
One of the hallmarks of viral immune evasion is the capacity to disrupt major histocompatibility complex class I (MHCI)
antigen presentation to evade T-cell detection. Cowpox virus encoded protein CPXV203 blocks MHCI surface expression by
exploiting the KDEL-receptor recycling pathway, and here we show that CPXV203 directly binds a wide array of fully
assembled MHCI proteins, both classical and non-classical. Further, the stability of CPXV203/MHCI complexes is highly pH
dependent, with dramatically increased affinities at the lower pH of the Golgi relative to the endoplasmic reticulum (ER).
Crystallographic studies reveal that CPXV203 adopts a beta-sandwich fold similar to poxvirus chemokine binding proteins,
and binds the same highly conserved MHCI determinants located under the peptide-binding platform that tapasin, CD8,
and natural killer (NK)-receptors engage. Mutagenesis of the CPXV203/MHCI interface identified the importance of two
CPXV203 His residues that confer low pH stabilization of the complex and are critical to ER retrieval of MHCI. These studies
clarify mechanistically how CPXV203 coordinates with other cowpox proteins to thwart antigen presentation.
Citation: McCoy WH IV, Wang X, Yokoyama WM, Hansen TH, Fremont DH (2012) Structural Mechanism of ER Retrieval of MHC Class I by Cowpox. PLoS Biol 10(11):
e1001432. doi:10.1371/journal.pbio.1001432
Academic Editor: Hidde L. Ploegh, Whitehead Institute, United States of America
Received July 19, 2012; Accepted October 17, 2012; Published November 27, 2012
Copyright:  2012 McCoy IV et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the NIAID R01 AI019687, U54 AI057160 (MRCE) and the Center for Structural Genomics of Infectious Diseases
(CSGID) contract numbers HHSN272200700058C and HHSN272201200026C. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Abbreviations: b2m, beta-2 microglobulin; BLI, biolayer interferometry; CK, chemokine; CKB, chemokine binding; CKBP, chemokine binding protein; co-IP, co-
immunoprecipitation; CPXV, cowpox virus; CRT, calreticulin; CTL, cytotoxic T lymphocyte; ER, endoplasmic reticulum; GFP, green fluorescent protein; HC, heavy
chain; ka, on-rate; kd, off-rate; KDELR, KDEL receptor; MAb, monoclonal antibody; MALS, multi-angle light scattering; MC, main-chain; MEF, murine embryo
fibroblast; MHCI, major histocompatibility complex class I; NK, natural killer; NKR, natural killer cell receptor; PLC, peptide loading complex; SPR, surface-plasmon
resonance; TAP, transporter associated with antigen processing; TL, thymic leukemia tumor antigen, Tpn, tapasin; UNP, UniProt
* E-mail: fremont@wustl.edu
Introduction
Detection of viral infection by CD8 T cells relies on major
histocompatibility complex class I (MHCI) presentation of virally
derived peptides at the cell surface. Not surprisingly, a wide variety
of viruses have evolved mechanisms to disrupt antigen presenta-
tion by targeting the assembly and trafficking pathways used by
MHCI proteins [1,2]. The most common immune evasion
mechanism appears to be blockade of cytosol-to-endoplasmic
reticulum (ER) peptide transport by the transporter associated
with antigen processing (TAP) [3–10]. However, other viruses
target molecular chaperones to impair the quality of peptide
loading without curtailing peptide supply [11,12]. The quality of
peptide loading by MHCI is initially controlled by the peptide
loading complex (PLC) made up of TAP, tapasin (Tpn), ERp57,
and calreticulin (CRT) [13]. Prior to binding an optimal peptide,
the PLC retains in the ER nascent MHCI heavy chains (HCs)
assembled with beta-2 microglobulin (b2m). Within the PLC, the
MHCI-dedicated chaperone Tpn bridges the HC/b2m complex
with TAP. Once a peptide of suitable affinity binds to the HC/
b2m complex, the fully assembled MHCI is released from the PLC
to transit to the cell surface; and perhaps not surprisingly, there are
examples of viral immune evasion proteins that impair peptide
loading by blocking PLC assembly [11,12]. In addition to PLC-
imposed quality control, non-PLC-associated CRT uses a KDEL-
dependent mechanism to retrieve suboptimally loaded MHCI
from the early Golgi to the ER to improve peptide binding [14].
This ER retrieval is dependent upon the C-terminal KDEL
sequence of CRT that confers binding to the KDEL receptor
(KDELR) in the early Golgi in a pH-dependent manner [15].
Several viral immune evasion proteins appear to directly target
MHCI proteins, but only adenovirus (AdV) E3-19K and human
cytomegalovirus (HCMV) US2 have been shown to directly bind
MHCI luminal domains [16,17]. E3-19K impairs MHCI egress
from the ER by either an ER-retention mechanism dependent on
its cytoplasmic tail [18] or its ability to prevent Tpn bridging
MHCI to TAP [11], while US2 targets MHCI for ER-associated
degradation (ERAD) [19]. E3-19K and US2 both exhibit distinct
class Ia allele preferences [20–22] that may help these viruses
evade natural killer (NK) cell cytotoxicity on the basis of missing
self [23]. Alternatively, viruses may encode separate proteins to
undermine NK cell surveillance [24]. Interestingly, E3-19K has
also been reported to target various MHCI assembly intermedi-
ates, and mutagenesis analyses suggest that E3-19K may interact
with an MHCI surface similar to that bound by US2 [20,22]. The
only structural study of direct MHCI sabotage revealed that US2
uses an Ig-like fold to bind under the MHCI-binding platform
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near where the N-terminus of the peptide is anchored [25].
Although US2 was crystallized bound to fully assembled MHCI,
cellular studies suggest US2 also targets HC before full assembly
with peptide and/or b2m [26]. In any case, the structural basis for
how US2, E3-19K, or any other viral immune evasion protein
discriminates MHCI alleles and/or assembly intermediates has not
been previously reported.
While many viruses exhibit strict host specificity, some
orthopoxviruses are able to productively infect a wide variety of
mammalian species and encode an array of immunomodulatory
genes that target both cell intrinsic and extrinsic antiviral
responses [27]. Yet until recently, orthopoxviruses were not
known to target antigen presentation. The orthopoxvirus cowpox
(CPXV) expresses two unrelated immune evasion proteins,
CPXV012 and CPXV203 (UniProt [UNP]: Q8QMP2), which
use different mechanisms to block antigen presentation in both
human and murine cells [28–30]. CPXV012 is a small type II
transmembrane protein that blocks peptide transport by TAP
[29,30]. By contrast, CPXV203 is a soluble protein that prevents
MHCI proteins from trafficking to the plasma membrane by a
mechanism dependent upon its C-terminal KTEL sequence, a
motif recognized by the KDELR [28]. To initially probe binding
partners, Byun et al. (2007) showed that CPXV203 co-
precipitated with MHCI and not TAP. These findings implied
that CPXV203 binds MHCI lumenal domains or an associated
molecule before and/or after peptide assembly [28]. Further-
more, CPXV203 was found to down regulate MHCI proteins in
both murine and human cell lines during normal poxvirus
infection [29,30]. This ability to broadly inhibit MHCI by
CPXV203 may help explain productive CPXV zoonotic infection
of various mammalian species other than small rodents, the
apparent CPXV host reservoir [27]. Indeed, mutant cowpox
viruses lacking both CPXV012 and CPXV203 demonstrate
attenuated virulence in a cytotoxic T lymphocyte (CTL)-
dependent manner [29], in contrast to other viral proteins that
target MHCI that do not appear to significantly modulate
primary infection in vivo [31,32].
Here we provide a precise understanding of how CPXV203
binds to a broad array of MHCI complexes that includes both
classical and non-classical molecules. Biosensor studies indicate
that CPXV203 binds MHCI weakly at the pH found in the ER,
but the affinity and half-life are significantly augmented at the
more acidic conditions found in the Golgi. Crystallographic
analysis reveals that CPXV203 adopts a b-sandwich topology
reminiscent of poxvirus chemokine-binding proteins, and this
domain engages evolutionarily conserved MHCI determinants
available only on fully assembled MHCI. We also undertook
mutagenesis analysis that supports the structural model and
uncovered the critical functional role played by two CPXV203 His
residues in the pH regulation of complex stability. Together these
data suggest that CPXV203 works cooperatively with the
endogenous KDEL-mediated Golgi retrieval process to promis-
cuously target fully assembled MHCI, thereby preventing T-cell
killing of cowpox infected cells.
Results
CPXV203 Downregulates Fully Assembled MHCI
To ascertain which MHCI assembly state(s) is targeted by
CPXV203, association with the HC of murine H-2Kb (UNP:
P01901) was monitored by co-precipitation in wild-type and b2m-
deficient cells. CPXV203 only co-precipitated with Kb HC in cells
expressing b2m (UNP: Q91XJ8) (Figure 1A), suggesting that
heterodimer assembly is required for CPXV203/MHCI associa-
tion. To further assess whether this association was dependent
upon the PLC, CPXV203 was expressed by transduction in cells
lacking either TAP or Tpn, which present low levels of fully
assembled MHCI. As shown in Figure 1B, CPXV203 dramatically
reduced MHCI surface expression in cells lacking TAP or Tpn,
whereas the TAP inhibitor CPXV012 did not affect surface
expression in these PLC-component deficient cells. We also found
that CPXV203 comparably downregulates MHCI expression in
cells with and without CRT (Figure 1C), suggesting that
CPXV203 expression does not grossly disrupt CRT-associated
ER quality control as could potentially occur through KDELR
competition. In further support of this conclusion, CPXV203 does
not interfere with PLC assembly, as shown by normal TAP/Tpn
association and normal steady-state levels of CRT (Figure 1D).
Previous studies found comparable peptide loading in cells with
and without CPXV203, and failed to identify association of
CPXV203 with the PLC [28]. Taken together, these findings
provide compelling evidence that CPXV203 regulates the surface
expression of fully assembled MHCI after dissociation from the
PLC without impairing PLC function.
CPXV203 Engages MHCI in a pH-dependent Manner
We next sought to examine whether CPXV203 directly binds to
MHCI using soluble recombinant proteins in biophysical assays.
We observed that CPXV203 binds Kb with an affinity of
KD,Kin = 480 nM at pHER 7.4 using surface-plasmon resonance
(SPR) (Figure 2A). The expansion of these studies to additional
MHCI molecules revealed that CPXV203 exhibits low affinity
interactions (KD,Kin = 82–10,500 nM) with five different murine Ia
alleles (Db, Dq, Kb, Kd, Ld) and a primate allele (Ceat-B*12) (Table
S1). We also examined a non-classical MHC Ib protein, murine
thymic leukemia tumor antigen or TL (T3b), which was engaged
by CPXV203 with similar affinity and kinetics at pHER 7.4 as
observed for Kb. Unlike classical MHCI proteins that require
peptide loading to assemble, TL pairs with b2m and is stable in the
absence of ligand binding. Thus, it appears that the requirement
for peptide binding to classical MHC Ia proteins for CPXV203
Author Summary
Viruses encode a wide array of proteins whose principle
function is to disable the surveillance and effector
functions of the immune system. A common viral target
is the MHC class I antigen processing and presentation
pathway, which is a potent mechanism used by the host
for the detection and killing of virally infected cells. In this
study we have delineated the immune evasion mechanism
of the cowpox-encoded CPXV203 protein, which is known
to potently block the normal trafficking of MHCI from the
endoplasmic reticulum (ER) to the plasma membrane.
CPXV203 does this by highjacking an ER-retrieval system
that usually serves to capture defective, chaperone
complexed MHCI proteins in the Golgi and send them to
the ER. We show that CPXV203 adopts a compact beta-
sandwich structure and engages evolutionarily conserved
MHCI determinants that are located under the peptide-
binding platform. The viral protein binds a variety of
different MHCI proteins weakly at the pH found in the ER,
but the affinity and half-life are significantly augmented at
the more acidic conditions found in the Golgi. Together
these data suggest that CPXV203 works cooperatively with
the endogenous ER retrieval process to promiscuously
target fully assembled MHCI, thereby preventing T-cell
killing of cowpox infected cells.
Structure of CPXV203/MHCI
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engagement is based on the role peptide loading plays in assembly
and stability rather than direct recognition. Promiscuous
CPXV203/MHCI association fits well with the previously
published data that CPXV203 downregulates murine H-2D and
-K alleles, though the affinities were weaker than those previously
reported for the viral ER retention protein E3-19K (11–18 nM)
[22].
The weaker than expected affinity of CPXV203 for MHCI led us
to evaluate a variety of buffer conditions that might more closely
reproduce ER/Golgi conditions (divalent cations: Ca2+, Mg2+,
Zn2+; ATP; pH 6–8). Of these changes, only low pH augmented
CPXV203/MHCI affinity with a decrease to pHGolgi 6.0 increasing
the affinity ,50-fold (KD,Kin = 10 nM, Figure 2B). This striking
enhancement occurs through both an increased on-rate (ka) and a
decreased off-rate (kd) for all tested murine and primate alleles
(Table S1). We confirmed these results using a separate biophysical
technique, biolayer interferometry (BLI), where the equilibrium
response of CPXV203 binding murine (H-2Dk, -Kb,k, -Ld; TL) and
primate MHCI (Mamu-A*01, Patr-B*0802) was monitored as a
function of pH (7.6–6.0) (Figure 2C). These binding studies
demonstrate that the stability of CPXV203/MHCI complexes is
pH regulated to favor association in the Golgi rather than the ER.
Importantly, similar observations have been made for the binding of
KDEL bearing ligands to the KDELR [15].
To address whether enhanced binding of CPXV203 to MHCI
at low pH results from changes in the stoichiometry of the
complex, multi-angle light scattering (MALS) experiments were
undertaken that demonstrated a 1:1 stoichiometry that was
insensitive to pH manipulation from pH 6.5–8.5 (Figure S1). We
also undertook circular dichroism spectra analysis that indicated
that the conformation of these proteins (alone or in complex) does
not change significantly as a function of pH (unpublished data).
These results support the 1:1 binding model used in our biosensor
analysis and suggest that CPXV203/MHCI pH regulation likely
involves only small local effects.
Structure of the CPXV203/MHCI Complex
We next pursued crystallographic studies of CPXV203 in
complex with MHCI to better understand the nature of the
interaction. Utilizing the observation that CPXV203 binding
affinity increases with decreasing pH, we crystallized SeMet-
labeled CPXV203 in complex with Kb loaded with SIINFEKL
(OVA257–264) at pH 5.55 and determined the structure at 3.0 A˚
resolution (Figure 3A; Table S2). Initial molecular replacement
phases using MHCI alone were greatly improved through cross-
crystal averaging (Figure S2A–S2D) [33], which allowed a
preliminary backbone trace of CPXV203 to be built. Subsequent-
ly, molecular replacement-single-wavelength anomalous disper-
sion (MR-SAD) was used to identify eight SeMet sites and
introduce anomalous phase information (figure of merit [FOM]
0.604) that improved map quality to the point where the complete
CPXV203/MHCI complex could be built and refined. The
Figure 1. CPXV203 downregulation of MHCI is b2m-dependent but PLC-independent. (A) Hemagglutinin-tagged CPXV203 (CPXV203-HA)
stably expressed in b2m2/2 cells was unable to co-IP HC. (B) MEFs lacking TAP/Tpn were transduced with CPXV203/CPXV012-IRES-GFP and then
MHCI surface expression was monitored by flow-cytometry. B6-derived MEF cell lines expressing TAP/Tpn typically have a mean fluorescence of MHCI
surface expression of around 200 as shown in the CRT add-back control in (C), lower left. Data in (B) demonstrate that CPXV203 does not require PLC
components to downregulate MHCI, while CPXV012 is TAP/Tpn-dependent. (C) Extension of the studies in B to CRT2/2 cells showed that CPXV203
function is independent of CRT. (D) Stable expression of CPXV203 did not impair TAP/Tpn association as monitored by co-IP, and CPXV203 did not
reduce steady-state levels of CRT found in cell lysate. Numbers at the top of dot plots in (B) and (C) indicate the mean fluorescence intensity of GFP-
negative and -positive populations.
doi:10.1371/journal.pbio.1001432.g001
Structure of CPXV203/MHCI
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Figure 2. CPXV203 binds MHCI with higher affinity at low pH. (A,B) SPR analysis of CPXV203/Kb binding at pHER 7.4 (A) and pHGolgi 6.0 (B).
Neutravidin was used to capture site-specifically biotinylated MHCI prior to injection of increasing concentrations of CPXV203. Non-specific binding
was addressed via reference subtraction of a neutravidin-only control flow cell. SPR curves (grey) were fit kinetically using a 1:1 Langmuir model
(black lines). See Table S1 for additional MHCI alleles and Figure S1 for analysis of protein oligomeric state. CPXV203 did not bind b2m alone (pH 6.0/
7.4, unpublished data). (C) Equilibrium BLI analysis confirmed CPXV203 affinity increased for murine/primate MHC Ia/Ib alleles as pH decreased from
7.6 to 6.0. Neutravidin sensors captured site-specifically biotinylated MHCI prior to immersion in samples of varying pH with constant [CPXV203]. The
[CPXV203] chosen for this experiment produced the lowest detectable signal at pHER 7.4 for each MHCI. Nonspecific binding was addressed using
both reference subtraction (neutravidin) and standard blocking reagents (1% BSA +0.05% TWEEN). *Indicates complex includes murine b2m instead
of human b2m.
doi:10.1371/journal.pbio.1001432.g002
Figure 3. Crystal structure of CPXV203 bound to MHCI. (A) Ribbon diagram of the complex structure of CPXV203 (magenta), Kb (blue), b2m
(grey), and OVA257–264 (yellow, spheres). No N-linked glycosylation sites are present near the interface. Membrane proximal domain shifts, a3 (7.2u)
and b2m (16.8u), are within the range observed in previous crystal structures of free MHCI (see Text S1). (B) Comparison of CPXV203/MHCI binding
orientation to other MHCI binders: viral (US2) [25], chaperone (Tpn), co-stimulatory (CD8aa) [35], and NK receptor (Ly49C) [40]. Chains colored as in A.
Proposed Tpn contact loops (a2 128–136, a3 222–229) are colored magenta with contacts identified by mutagenesis shown as spheres [36,37,39,52].
See also Table S2 and Figure S2.
doi:10.1371/journal.pbio.1001432.g003
Structure of CPXV203/MHCI
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structure reveals that CPXV203 binds below the MHCI peptide-
binding platform, contacting both the HC (a2- and a3-domains)
and b2m. Comparison of Kb free and bound by CPXV203 did not
indicate any significant changes associated with viral protein
engagement. The general footprint located below the a2-1 helix of
Kb is supported by serological experiments whereby we deter-
mined whether CPXV203 competed with monoclonal antibodies
specific for well-characterized epitopes. Direct binding competi-
tion was observed for two monoclonal antibodies (MAbs) (AF6-
88.5.3 and Y-3) that have been mapped precisely to this region,
and no competition was observed for three MAbs mapped outside
of the CPXV203 footprint (Figure S2F–S2H). We note that while
HCMV US2 also binds MHCI below the peptide-binding
platform, the CPXV203 footprint is completely distinct and,
strikingly, overlaps with that of Tpn, CD8, and NK cell receptors
(NKRs) (Figure 3B).
CPXV203 Is Structurally Related to Poxvirus Chemokine-
Binding Proteins
The structure of CPXV203 does not resemble any structurally
characterized viral or host protein known to interact with MHCI.
The single domain of CPXV203 (209 aa) is a globular b-sandwich
that is stabilized by five disulfide bonds conserved in all T4
poxvirus protein family members (Figures 4A, 4B, S3A). The core
b-sandwich consists of two parallel b-sheets (b-sheet I: b1, b5, b6,
b10; b-sheet II: b2, b3, b4, b7, b8, b9) made up of anti-parallel
strands with one parallel strand interaction (b7/b9) bridging the
two segments of b-sheet II (Figure 4B). Three of these disulfide
bonds appear to stabilize the h4-loop-h5 arrangement used to
engage the MHCI a2-domain. A search for structurally similar
proteins indicates that the CPXV203 b-sandwich core resembles
the structurally characterized poxvirus chemokine binding pro-
teins (CKBPs), such as the vCCI-like protein encoded by
ectromelia virus, EVM001 [34], which exhibits an RMSD of
3.0 A˚ for 143 aligned residues (Figure S3B; Table S3).
CPXV203 and the poxvirus CKBPs engage their ligands using
completely distinct binding surfaces located on opposite faces of the
b-sandwich core (Figure 4C). While vCCI-like proteins use b-sheet
II to bind chemokines, CPXV203 primarily uses b-sheet I elements.
Interestingly, the Ectromelia virus CrmD-CTD (SECRET domain)
also appears to use b-sheet I elements to bind chemokines, and it
shares with CPXV203 a distinct b7–b9 junction relative to vCCI-
like proteins that increases b-sheet I accessibility through the
conversion of a flexible loop into a b-sheet II strand (Figure 4D).
CPXV203 has further differences with the vCCI core with the
replacement of vCCI b13-b14 with two a-helices (h4 and h5), a
modification that also exposes CPXV203 b10 to interact with b2m.
For CPXV203, these topological changes remove potential steric
clashes (Figure S3C), increase solvent-accessibility of the conserved
b5–b6 loop (source of nearly all a3 contacts), and create the primary
sources for both a2 (h4–h5) and b2m (b8 and b10) contacts
(Figure 4B; Table S4). Thus, while CPXV203 is clearly structurally
related to poxvirus CKBPs, significant modifications are clearly
evident that uniquely allow it to recognize MHCI.
CPXV203 Contacts Conserved Elements within Each
MHCI Domain
To understand the structural basis of how CPXV203 interacts
with such diverse MHCI-family proteins, we analyzed the
conservation of MHCI contacts and the similarity of these contacts
to those used by other MHCI-binding proteins. CPXV203
promiscuously binds MHCI through a large, somewhat nonpolar
interface divided into three distinct contact regions (a2, a3, and
b2m domains) (Figures 5A, 5B, S4A, S4B). The arrangement of
these contact regions is only available in fully assembled MHCI, and
as such CPXV203 binds MHCI in an assembly-dependent manner
that is peptide-independent as long as MHCI assembly is also
peptide-independent, as is the case for TL. Comparison of the
CPXV203/MHCI interface to similar interfaces reveals that the
total buried surface area (BSA) is significantly larger than most other
complexes, CPXV203 buries.200 A˚2 more main-chain (MC) than
any similar MHCI-binder, and only CPXV203 divides its interface
nearly equally among the platform (a1/a2), b2m, and a3
(Figure 5A; Table S5). CPXV203 recognizes MHCI elements that
are extremely well conserved in all murine pMHCI: overall, 86%;
CPXV203 contacts, 91%; CPXV203 side chain (SC) contacts,
95%; five invariant SC contacts. Further, CPXV203 recognizes
core structural features of the MHCI fold by anchoring each of the
three domain interfaces through a buried MC-MC hydrogen bond
and two to three MC-SC hydrogen bonds (Figure S4C–S4E; Table
S4). Through these contacts, CPXV203 recognizes seven backbone
positions conserved by the MHCI fold and coordinates conserved
MHCI side chains within the a3 interface (Q226, D227, E229) also
required for Tpn and CD8 association [35–37]. Further, the
presence of CPXV203 His residues opposite negatively charged a3
domain residues (H75-D227, H80-E229) suggests these may be pH-
regulated interactions, though only H80-E229 is close enough to
form a direct contact (3.5 A˚ versus 7.3 A˚). Finally, we have
identified that CPXV203 downregulates the non-classical MHCI
molecule H2-M3, while mCD1d escapes CPXV203 retrieval
(Figure S4F, S4G). Our structural results support the idea that
escape by mCD1d is facilitated in part by a charge reversal at
position 229 (mCD1d H233 – CPXV203 H80) and the orientation
of mCD1d Q230 away from the interface due to an altered CD-
loop conformation (Figure S4H). This structural investigation
explains promiscuous MHCI retrieval by CPXV203, as it
specifically targets a tri-domain interface of evolutionarily conserved
contacts that would only be presented by fully assembled MHCI.
Critical Role of CPXV203 His-75 and His-80 in pH-
Regulated MHCI Interactions
We assessed the functional relevance of specific determinants
within the CPXV203/MHCI binding interface by extensive
mutagenesis of both CPXV203 and Kb. Mutants were assayed
for loss of function by rescue of surface Kb expression or lack of
physical association by co-immunoprecipitation (co-IP). Single
mutations in either Kb or CPXV203 from all three interaction
sites (Figure 5) were tested, but only a3 interface mutations Kb
E229Y and CPXV203 F76A significantly rescued Kb surface
expression (Figure 6A, 6B). Furthermore, double mutations within
the a3 interface (Kb D227K/E229Y, CPXV203 H75A/H80A, Kb
Q226A/CPXV203 F76A, Kb E229Y/CPXV203 H75A, Kb
E229Y/CPXV203 F76A) or the simultaneous mutation of
interfaces a2 and a3 (CPXV203 Y161A, F76A) significantly
enhanced Kb rescue, with some mutants displaying complete
ablation of CPXV203 function (Figure 6A–6C). Physical associ-
ation (CPXV203-HA/Kb) was impaired more dramatically than
Kb rescue by single a3 interface mutations (Figure 6D), though it
should be noted that the HA-tag might impair association. In any
case, these experiments clearly demonstrate the functional
importance of our structurally defined interface in CPXV203-
mediated MHCI association and retrieval.
To extend these findings, biosensor studies were undertaken to
probe the contribution of individual interface residues in binding
and pH regulation. Equilibrium analysis (BLI, pHER 7.4) of
CPXV203 and MHCI mutants further confirmed the three-site
binding footprint (Figure 5) and clearly distinguished the
Structure of CPXV203/MHCI
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Figure 4. Structural topology of CPXV203 and comparison to poxvirus CKBPs. (A–D) CPXV203 regions used to contact a2, a3, and b2m
domains are indicated. (A) Ribbon diagram of CPXV203 (R5-S190) colored according to 2u structure (cyan a helices, blue 310 helices, green b strands,
grey loops, and yellow disulfide bonds). CPXV203 orientation is identical to Figure 3A. (B) Topology diagram of CPXV203 with 2u structure coloring as
in (A). Disulfide bonds are shown as flattened balls-and-sticks with residue positions listed. The core b sandwich is divided into its b sheets by a
dashed, grey line. Structural elements not found in vCCI (PDB: 1CQ3) are highlighted in black, including the absence of a highly negatively charged
chemokine-binding (CKB) loop. MHCI a2 and b2m contacts are highly localized to these unique structural elements. (C) CPXV203 and poxvirus CKBPs
(RPV vCCI and ECTV CrmD-CTD) use three distinct surfaces for ligand binding. Each CKBP/chemokine (CK) complex (PDBs: 3ONA [53] and 2FFK [54])
was aligned to CPXV203 using CE [55]. The view from Figure 3A has been rotated 290u (y-axis). Complexes are shown as ribbon diagrams: CPXV203
and CKBP (magenta), core b-sandwich (green), H-2Kb (blue), b2m (grey), OVA257–264 (yellow, spheres), CK (cyan). (D) CPXV203 and CKBPs are shown
after a further 290u y-axis rotation to highlight the distinct b7–b9 junction found in CPXV203 and CrmD-CTD relative to vCCI-like proteins. The
absence of a CKB loop in CPXV203 and CrmD-CTD relative to vCCI is also indicated. See also Tables S3, S4, and Figure S3.
doi:10.1371/journal.pbio.1001432.g004
Structure of CPXV203/MHCI
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CPXV203 binding site from those of E3-19K, US2, and MAb Y-3
(Table S6). Alanine mutation of several CPXV203 residues within
the a3-domain interface (including His residues 75 and 80) had a
pronounced deficit in binding (similar to co-IP). CPXV203 H75
and H80 were selected for kinetic analysis (SPR) based on their
chemical environment (Figure S4E) and previously described
sensitivity to alanine mutation (functional and association). Alanine
mutation of either His ablated the off-rate (kd) enhancement at low
pH, while maintaining a similar on-rate (ka) enhancement
(Figure 6E; Table S7). Thus at low pH, a3 interface His residues
act to extend the CPXV203/MHCI half-life (6 s–73 s), while a
separate interaction appears to regulate the faster association (ka)
observed at low pH. Consistent with their importance, the double
mutant (H75A, H80A) displayed extremely weak affinity that
prohibited accurate kinetic analysis, though equilibrium BLI
assays clearly support the greater functional deficit observed for
this mutant (Table S6). These investigations indicate that
CPXV203 engages MHCI through critical pH-regulated interac-
tions with conserved MHCI a3-domain determinants, while the
a2 and b2m domain interfaces may enable CPXV203 to bind fully
assembled MHCI with broad specificity.
Discussion
Viral infection of mammalian hosts can be greatly facilitated by
viral proteins that confer the ability to evade CTL detection and
clearance. Not surprisingly, viruses have evolved a wide variety of
strategies to reduce cell surface presentation of viral peptides on
MHCI [1,2]. The cellular, structural, and biophysical results
reported here provide a complete picture of one such strategy, as
CPXV203 was shown to directly bind fully assembled MHCI in a
manner that is regulated via the normal pH gradient that exists
between the ER and Golgi compartments (Figure 7). Though
CPXV203 makes contacts to three distinct MHCI domains, pH
regulation of the complex half-life is critically dependent on
CPXV203 His residues that bind to an a3-domain acidic CD loop
important for both Tpn and CD8 association. Thus, CPXV203
exploits a cellular pathway to target MHCI surfaces critical for
immunological function in a manner that selects for those MHCI
molecules most likely to present viral peptides.
Remarkably, CPX203 is not related to any other MHCI-
binding protein, but rather it is most structurally related to
poxvirus CKBPs. To our knowledge, CPXV203 is the first
member of the large T4 poxvirus protein family [38] to be
structurally characterized, suggesting a previously underappreci-
ated link between the poxvirus CKBPs and T4 protein families
through similarities in their b-sandwich core. Regardless of the
evolutionary history, the adaptation of this protein domain to
structurally distinct ligands and unrelated functional outcomes
suggests the integral role that CPXV203 plays in antigen
presentation disruption may not be its only function.
CPXV203 evolved into a promiscuous MHCI-binding protein by
targeting MHCI determinants that are largely conserved by virtue
of their roles in the recognition by host factors essential to cellular
immunity (Tpn, CD8, NKRs). For instance, many a2-domain
contacts (R111, Q115, E128, T134) are conserved through Tpn (a2
128–136) [37,39] and Ly49 (R111, Q115, D122) [40] interactions,
while the b2m contacts primarily involve structurally conserved
backbone positions within the LIR-1/MHCI interface [41]. The
direct overlap of CD8 and Tpn contact sites (Q226, D227, E229)
[35–37] in the acidic CD loop of the a3 domain is clearly exploited
by CPXV203 for MHCI binding, and this interface is precisely
where we have identified two His residues in the viral protein that
regulate increased kinetic stability at the lower pH of the Golgi.
Previous investigations of pH-dependent endosomal (PRL/
PRLr [42], FcRn/Fc [43]) and ERRGolgi (RAP/LRP) [44]
trafficking have repeatedly identified His residues as the pH
sensitive component of these regulatory mechanisms. Unlike other
amino acids, histidine is well suited to serve this function, as small
pH shifts can drastically change the charge and hydrogen-bonding
potential of this residue. As such, our investigation of CPXV203/
MHCI pH regulation focused on interface histidines, which
revealed a significant contribution of CPXV203 H75 and H80 to
complex half-life at low pH. We suggest that these titratable His
residues endow CPXV203 with the ability to regulate fully
assembled MHCI in a manner that is complementary to the
regulation of PLC-associated MHCI by CPXV012.
The specific binding of CPXV203 to fully assembled MHCI
proteins in a pH-dependent manner clarifies mechanistically how
CPXV203 coordinates with CPXV012 to effectively block antigen
presentation. Previous characterizations showed the CPXV012
Figure 5. CPXV203 binds conserved elements within each
MHCI domain. The CPXV203/MHCI complex is shown as a Connolly
surface (1.4 A˚ probe). Relative to Figure 3A, MHCI was rotated 230u (y-
axis), while CPXV203 was rotated 60u (y-axis). Each domain-specific
interaction is circled on both molecules. The US2 and E3-19K binding
sites are also indicated. (A) CPXV203/MHCI surfaces are colored by chain
(see Figure 3A) or by contact (see legend). CPXV203/MHCI interfaces are
labeled according to the contacted MHCI domain. Each MHCI domain is
contacted by a CPXV203 surface that is localized to a distinct structural
region. Comparison of the CPXV203 and US2/E3-19K sites clearly shows
the lack of binding site overlap between PLC-proximal and PLC-distal
immune evasion proteins. (B) Conservation of interface residues is
shown for CPXV203-susceptible MHCI and T4 poxvirus proteins (see
Figures S4A and S3A, respectively). Backbone contacts for each
interface are indicated (*). CPXV203 contacts highly conserved MHCI
surfaces, as opposed to US2 (prominent variable residues between a2–
a3). Conservation of MHCI contact residues in the T4 family are highly
localized to the a3 interface, which contains 4/6 CPXV203 backbone
contact positions. See also Figure S4 and Table S4 and S5.
doi:10.1371/journal.pbio.1001432.g005
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functions in a PLC-dependent fashion to block TAP transport of
peptide into the ER [29,30]. However, some MHCI-binding
peptides in the ER are not TAP-dependent and the CPXV012
block of peptide transport is likely not absolute. The MHCI proteins
that are able to bind peptide in the presence of CPXV012 are left to
CPXV203, since it binds fully assembled MHCI through domain-
specific conformational determinants conserved in classical and
many non-classical MHCI. Among these interactions, the a3
Figure 6. Mutagenesis supports a tri-domain interface and pH regulation. (A–C) 3KO cells stably transduced with b2m and Kb (3KO-b2m-Kb)
were transduced with CPXV203-IRES-GFP to evaluate the effect of CPXV203/MHCI interface mutation on surface Kb remaining relative to
untransduced cells. Comparable expression of wild-type and mutant proteins was determined using co-expressed GFP and/or western blotting. Each
figure represents the data from two independent experiments. **p,0.01; ***p,0.001 when compared with wild type. Limited MHCI escape was
observed for two single a3 interface mutations (Kb E229Y or CPXV203 F76A), while significant Kb escape required double mutation of the a3 interface
(Kb D227K/E229Y, CPXV203 H75A/H80A, Kb Q226A/CPXV203 F76A, Kb E229Y/CPXV203 H75A, Kb E229Y/CPXV203 F76A) or simultaneous mutation of
interfaces a2 and a3 (CPXV203 F76A, Y161A) (D) Most mutant CPXV203-HA exhibited a decreased ability to co-IP Kb even though surface Kb (%) did
not increase significantly. CPXV203/Kb mutations that significantly increased surface Kb expression also exhibited a decrease in total Kb (lysate),
indicative of the release of MHCI retention [28]. (E) Kinetic analysis (SPR) of alanine mutation of a3 interface histidines (CPXV203 H75 and H80)
summarized by on-rate (ka, (+)-axis) and half-life (half-life, (2)-axis). (F) Summary of mutagenic analysis (functional and biosensor) mapped to
CPXV203/MHCI structure (same colors as Figure 3A) shown as cartoon loops except for the peptide (spheres). Mutated residues (Ca spheres) were
colored to indicate whether they had a significant effect (red) or no significant effect (grey). CPXV203 and MHCI have been translated apart (x-axis) to
highlight corresponding interface mutations. See also Tables S6, S7.
doi:10.1371/journal.pbio.1001432.g006
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interface is particularly important based on the presence of
CPXV203 His residues that impart pH regulation to the
CPXV203/MHCI interaction. This pH dependence suggests that
CPXV203/MHCI interacts most avidly in the Golgi and not the
ER, thus limiting the pool of MHCI that CPXV203 must retrieve.
Interestingly, CRT has a C-terminal KDEL sequence confer-
ring ER retrieval, and non-PLC-associated CRT has recently been
implicated in quality control of MHCI peptide loading [14]. More
specifically, CRT was shown to accumulate in the cis-Golgi and
return peptide accessible MHCI proteins to the ER. Both CRT
and CPXV203 retrieve MHCI proteins but with opposite goals.
CRT functions in host quality control by retrieving MHCI with
suboptimal peptides, whereas CPXV203 functions in immune
evasion by retrieving fully assembled MHCI to block antigen
presentation. Thus CPXV012 and -203 act sequentially to
efficiently block MHCI expression using PLC-dependent versus
PLC-independent mechanisms, respectively. As a possible conse-
quence of efficient MHCI downregulation resulting in NK cell
susceptibility, CPXV expresses the soluble class I-like protein
OMCP that functions as a competitive antagonist of the NKG2D-
activating receptor [24]. Indeed, the combined sabotage of both
CTL and NK cell detection of virus-infected cells explains why
mutant CPXV lacking CPXV012 and 203 demonstrates attenu-
ated virulence in vivo compared to wild-type virus [29].
Methods
Antibodies
MHCI-specific MAbs used in SPR competition assays were
obtained from the ATCC (H-2Kb: 25-D1.1.6, B8-24-3, Y-3),
purchased from BioLegend (Kb: AF6-88.5.3, Kb/Db: 28-8-6, Kd/
Dd: 34-1-2S, hb2m: 2M2), or provided as a kind gift (Kb: 5F1-2-
14) from S. Nathenson (Albert Einstein College of Medicine, New
York) and L. Pease (Mayo Clinic, Minnesota). MAbs that were not
purchased from BioLegend were purified from ascites on a Bio-
Rad Profinia FPLC using Protein A or G. MAbs used in flow-
cytometry and IP assays have been described previously. MAb
footprints in Figure S2H are based on SPR data from this work
and available literature (Text S1).
Peptides
Peptides were synthesized by Fmoc chemistry and then
subjected to reverse-phase HPLC for purification. Peptides were
resuspended at .1 mM in ddH2O, DMSO, or 6M GuHCl, as
dictated by peptide solubility. Peptides were chosen based on
available MHCI crystal structures or personal suggestions by A.
Stout (NIH Tetramer Core Facility). See Text S1 for a list of all
peptides used in this study.
Cell Lines
Murine embryo fibroblast (MEF) B6/WT3 (WT3) and mutant
MEFs including TAP1-deficient cells (FT12), Tapasin-deficient
cells (Tpn2/2), calreticulin-deficient cells (CRT2/2), b2m-deficient
cells (B6.B2M2) and triple knockout fibroblasts (Kb2/2 Db2/2
b2m2/2; 3KO) were all derived from C57BL/6 (H-2b) embryos
and have been described previously [45]. The CPXV203 and Kb
mutants were stably expressed in the indicated cells by retroviral
expression vectors pMXsIG [28] and pMIN [45], respectively. Cells
transduced by pMIN were selected by neomycin while green
fluorescent protein (GFP+) cells from pMXsIG transduced lines
were enriched by cell sorting.
Immunoprecipitations, Immunoblot, and Cross-linking
For co-IPs (TAP1/Tpn and CPXV203-HA/H-2Kb), cells were
lysed in PBS with 1.0% digitonin (Wako) and protease inhibitor
cocktails (Roche) for 60 min. Post-nuclear lysates were then
incubated with indicated antibodies + protein A-sepharose (Sigma)
or anti-HA sepharose (sigma) for HA-tagged CPXV203 for 1 h.
After washes, coprecipitated proteins were eluted by boiling in
lithium dodecyl sulfate (LDS) sample buffer (Invitrogen). For cross-
linking treatment (CPXV203-HA/H-2Kb), cells were incubated
with 1–2 mM DSP (Thermo) in PBS for 2 h at 4uC. The cross-
linking was terminated with 25 mM Tris-HCl pH 7.4 before the
cells were lysed in PBS with 1.0% NP-40. Following immunopre-
cipitation cross-linked proteins were eluted by boiling in LDS
sample butter with 2.5% b-mercaptoethanol. Immunoblot of
precipitated proteins was performed following SDS-PAGE sepa-
ration. Specific proteins were visualized by chemiluminescence
using the ECL system (Thermo).
Flow Cytometry
All flow cytometric analyses were performed using a FACS
Calibur (Becton Dickinson). Data were analyzed using FlowJo
software (Tree Star). Staining was performed as described [46].
PE-conjugated goat anti-mouse IgG (BD Pharmingen) was used to
visualize MHCI staining. PE-conjugated anti-mouse CD1d
Figure 7. CPXV203 co-opts the KDELR to retrieve MHCI from the Golgi. Comparison of the separate but complementary strategies
employed by CPXV012 and CPXV203 to downregulate MHCI. CPXV012 impairs nascent MHCI folding by inhibiting TAP, while CPXV203 selectively
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(eBioscience) was used to detect surface CD1d. GFP signal
representing CPXV203 transduced cells were collected in the
FITC channel.
Protein Production
Mammalian CPXV203DKTEL (aa 1–205, etgMVI-LHV), bac-
terial CPXV203DKTEL (aa 1–205, maMVI-LHV), and bacterial
MHCI were produced using established methods (Text S1). Kb (aa
0–280, mGPH-PST)/H-2Kd (aa 0–283, mGPH-VSN) constructs
were produced in house, while H-2Dd, H-2Dk, H-2Dq, H-2Kk, H-
2Ld, Mamu-A*01, Patr-B*0802, H-2Q9-H-2Db, H-2Kb-HLA-
A*0201, HLA-A*0201-H-2Kb were produced by the NIH Tetramer
Core Facility. H-2Db biotinylated monomer (LCMV Gp33,
KAVYNFATC) was purchased from Beckman Coulter. Biotinylated
constructs included a C-terminal site-specific biotinylation tag and
were biotinylated by following established procedures (Avidity).
Chimeric mCD1d-Fc produced in a murine cell line was obtained
from R&D Systems. All MHCI include human b2m (hb2m, aa 0–
99, mIQR-RDM, UNP: P61769) unless otherwise noted. Signal-
peptide/cloning artifacts are indicated as lower-case aa.
X-ray Structure Determination
CPXV203 (Brighton Red strain, SeMet-labeled)/MHCI-
(OVA257–264:H-2K
b:hb2m) complex was prepared for crystallization
by size-exclusion chromatography purification of CPXV203/MHCI
in low pH/salt buffer (50 mM NaCl, 30 mM MES pH 5.6, 0.01%
Azide). Diffraction-quality crystals of CPXV203/MHCI were grown
at 20uC by streak seeding into hanging drops of 0.5 ml complex
(7.5 mg/ml) +0.5 ml reservoir solution (10% PEG 6000, 4% glucose,
2% ethylene glycol, 0.1 M tri-K citrate pH 5.55, 0.01% Azide).
Crystals were dehydrated, flash frozen in liquid N2, and then used for
X-ray data collection at the Advanced Light Source (ALS) beamline
4.2.2 (0.97909 A˚ wavelength). Crystals belong to space group P1
(a = 88.31 A˚, b = 88.25 A˚, c = 106.42 A˚; a= 76.18u, b= 69.29u,
c= 66.69u) with four CPXV203/MHCI complexes per asymmetric
unit (ASU) and a solvent content of 52%. The HKL2000 software
package [47] was used to index, integrate, and scale the data, yielding
an 87.9% complete dataset at 3.0 A˚ (R-sym = 16.4%) (Table S2). The
structure of H-2Kbm8:mb2m (2CLZ) [48] was used for molecular
replacement (MR) using Phaser within the Phenix suite [49], with four
MHCI proteins located within the ASU. Electron density for the
unique CPXV203 region was improved by cross-crystal averaging [33]
allowing an initial model of CPXV203 to be manually built in Coot
[50]. MR-SAD using AutoSol (Phenix suite [49]) was subsequently
used to identify eight SeMet sites in the four CPXV203 monomers,
enabling the introduction of anomalous phase information (figure of
merit [FOM] 0.604) that improved map quality allowing for complete
CPXV203/MHCI model building. Phenix Refine [49] was used with
global non-crystallographic symmetry (NCS) restraints to refine the
CPXV203/MHCI structure to a final Rwork of 22.9% and Rfree 25.3%
(see Table S2 for complete crystallographic statistics). The final
CPXV203/MHCI model contains four CPXV203/MHCI complexes
and 72 water molecules. Each complex contains the nearly complete
CPXV203 (mature residues 5–190), Kb (mature residue 1–277),
human b2m (0M-99), and OVA257–264. All structure figures were
created using PyMOL [51]. See Text S1 for comprehensive
crystallization, data collection, structure determination, refinement,
structural analysis, and figure preparation details.
Biophysical Characterization of CPXV203/MHCI
Interaction
SPR experiments were run on a Biacore T100 (GE Healthcare) in
either standard HBS-EP+ (pH 7.4) or low pH MBS-EP+ (pH 6.0).
Kinetic and equilibrium analyses were performed using Biacore T100
Evaluation software using a 1:1 Langmuir model. BLI experiments
were performed on an Octet RED system (ForteBio) using HBS-EP+/
MBS-EP+ supplemented with 0.05% (v/v) TWEEN and 1% BSA.
Equilibrium BLI data was analyzed using Octet software (V7.0). All
biosensor experiments were run at 25uC and followed proper biosensor
experimental technique. Size-exclusion chromatography-multi-angle
light scattering (SEC-MALS) experiments were run on a Dawn
HELEOS-II 18-angle light scattering detector (Wyatt) and Optilab
rEX refractive index monitor (Wyatt) linked to a Waters HPLC system.
Dynamic light scattering (DLS) was performed on a DynaPro-801TC.
Circular dichroism was measured using a Jasco-810 instrument (Jasco
Inc.). Detailed methodologies for biosensor, light scattering, and
circular dichroism experiments are available in Text S1.
Supporting Information
Figure S1 Oligomeric state of CPXV203, MHCI, and
complex as a function of pH. (A,B) MALS was run on a
DAWN HELEOS system. All samples were applied at 1 mg/ml
(15–42 mM) and underwent SEC (20uC) on a WTC-030S5
column prior to entering the DAWN system. (A) CPXV203/
MHCI is a 1:1 complex at physiologic pH 7.4. These proteins
alone and in complex behave as single, well-behaved species with
MALS MW that matches the calculated MW. Complex analysis
utilized a high-affinity MHCI mutant (Y84A, C121S; see Table
S6) that did not dissociate during the course of SEC, as wild-type
complex dissociated during SEC at pHER 7.4. MALS analysis of
both wt and mutant MHCI produced MWMALS that matched
MWCalc for a MHCI heterotrimer. Mass spectrometry determined
MW for CPXV203 is also listed. (B) MALS evaluation of these
proteins from pH 8.5–6.5 indicates oligomeric state (alone or in
complex) remains constant across pH 8.5–6.5. Complex analysis
in this experiment again utilized the high-affinity MHCI mutant
(Y84A, C121S), which also exhibits pH-enhanced binding at low
pH (unpublished data). MALS analysis of wild-type complex
(unpublished data) showed a reduction in complex dissociation as
pH decreased, which correlates with the increased affinity
observed in biosensor experiments. Dynamic light scattering
(DLS) experiments run on a DynaPro-801TC supports stable 1:1
binding stoichiometry and stable oligomeric state from pH 7.5–5.4
for CPXV203 and wt MHCI (unpublished data).
(TIF)
Figure S2 CPXV203 electron density improvement and
validation. (A–C) Electron density (2s) in the CPXV203 region
is shown using phases from molecular replacement (A), cross-
crystal averaging (B), or the final model (C). MHCI is displayed as
in Figure 3A. The Ca trace of CPXV203 is shown in (C). Though
the contiguous density available for model building was signifi-
cantly improved by non-crystallographic symmetry (NCS), suc-
cessful model building required the improvement in estimated
phases from cross-crystal averaging against a large number of
MHCI complexes and free MHCI. (D) The cross-crystal averaged
electron density (1s) for part of CPXV203 b6 (black box) is shown
to illustrate the electron density that was available to initiate
CPXV203 model building using a stretch of residues with bulky
side chains (H80, Y82, E84, F85). SA-OMIT and 2Fo-Fc maps are
shown for comparison. All electron density images were produced
in PyMOL using isomesh at the designated s. (E) Stereo image of
the CPXV203 backbone trace is shown as sticks colored from N-
to C-terminus using a spectrum from blue to red, respectively.
Relative to Figure 3A, CPXV203 was rotated 60u (y-axis) to
optimize the view of the MHCI binding surface. Note the
structural elements unique to CPXV203 that are involved in
Structure of CPXV203/MHCI
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MHCI binding: b5–b6 hairpin loop (green), b8 (yellow), b10
(orange), h4–h5 (red). (F–H) Serological studies localized
CPXV203/MHCI interface below the a2-1 helix. (F) An SPR
adaption of a sandwich ELISA was used to evaluate the interface.
In brief, MAbs immobilized through amine coupling were used to
capture MHCI prior to an injection of tetramerized CPXV203.
An increased RU signal during the injection would indicate that
the MAb did not block the CPXV203/MHCI interface, while free
dissociation of MHCI would indicate the MAb blocked the
interface (directly or sterically). Examples of both outcomes are
shown. (G) MHCI from our structural work is shown as described
in Figure 3A with labels identifying MHCI domains and the a2-1
helix. (H) The mAb footprints are shown as shaded circles on
MHCI. Green indicates non-blocking antibodies, while red
indicates blocking antibodies. MAb footprints are based on
published cellular and structural studies (see Text S1). The AF6-
88.5.3 footprint was refined in this work through the observation
that this MAb does not recognize mutant H-2Kb (M228T) and
that it competes with Y-3.
(TIF)
Figure S3 CPXV203 alignments and modeling. (A,B)
Alignments of CPXV203 indicate residue conservation colored
by similarity (ACILMPV DE FHWY HKR NQST), experimen-
tally observed 2u structure (CPXV203, above; CPXV vCCI,
below), side chain accessibility (CPXV203, above; CPXV vCCI,
below), and MHCI contacts. CPXV203 histidines are marked with
an asterisk, except for pH-regulated interface histidines (see
Figure 6) that are labeled with blue/red circles. CPXV203 E162
is labeled with a blue/grey circle to indicate it is used in both the
a2 and b2m interfaces. Side chain solvent accessibility was defined
using NACCESS (1.4 A˚ probe); black circles, ,30% accessible;
grey circles, 30%–60% accessible; white circles, .60% accessible.
(A) The sequence of CPXV203 was aligned to T4 poxvirus
proteins with a broad range of sequence identity; taterapox
(TATV, 96%), monkeypox (MPXV, 64%), yokapox (YPV, 60%),
deerpox (DPV, 34%), and myxoma (MYXV, 26%). Virus strains
are indicated in parentheses. The C-terminal a-helix predicted by
all 2u structure prediction programs used in these studies is shown
in white. Cysteine residues (ten conserved positions) are boxed in
yellow, while the conserved C-terminal KDEL-variant is boxed in
red. Predicted N-linked glycosylation sites are boxed in green. As
CPXV203 N146 is not solvent-accessible, its lack of glycosylation
(mass spec and PNGase treatment, unpublished data) is not
surprising. (B) Structure-based alignment (Dali server) of
CPXV203 with various poxvirus CKBPs: ectromelia virus (ECTV)
CrmD C-terminal domain (CrmD-CTD) [1], vaccinia virus
(VACV) A41 [2], ECTV vCCI [3], rabbitpox (RPV) vCCI [4],
and cowpox virus (CPXV) vCCI [5]. Contact residues identified
through structural studies (CPXV203, CrmD-CTD, RPV vCCI)
or mutagenesis (ECTV vCCI) are shown above (MHCI) or below
(CK) the alignments. PDB IDs for proteins in this alignment:
3ON9, 2VGA, 2GRK, 2FFK, 1CQ3. (C) Poxvirus CKBPs vCCI
and CrmD-CTD were modeled (CE alignment of CKBP to
CPXV203 [6]) onto the CPXV203/MHCI complex to evaluate
potential steric clashes due to structural elements found in CKBPs
(blue) but absent in CPXV203. The complexes are shown using
the same representation, color scheme, and orientation as in
Figure 3A. All topological differences between CKBPs and
CPXV203 are listed. Connolly surfaces are shown for severe
clashes (#2 A˚).
(TIF)
Figure S4 CPXV203/MHCI interface analysis. (A,B)
Sequence alignment of MHCI regions contacted by CPXV203.
MHCI 2o structure, Tpn/CD8/NKR contacts, and side chain
solvent accessibility are shown above the alignments (see Figure S3
for additional alignment details). CPXV203/MHCI contacts are
boxed in magenta, while MHCI backbone contacts are indicated
with an asterisk above the alignment. (A) MHCI HC were included
in this alignment if they are downregulated or bound by CPXV203.
Murine CD1d was identified as a null allele in this study (see G), and
so it is shown below the other alleles to highlight the lack of sequence
conservation in CPXV203/MHCI contact regions. D227 and E229
are indicated with blue/red circles, as CPXV203 H75 and H80 are
believed to contact these Tpn contact residues in a pH-regulated
manner. (B) b2m sequences of potential poxvirus hosts are shown
(primate, rodent, livestock). Tpn contacts are based on published
mutagenesis work [7–10], while HBPLUS was used to identify CD8
and NKR contacts from all available complex structures (CD8/
MHCI: 1AKJ, 1BQH, 1NEZ, 3DMM; Ly49/MHCI: 1QO3,
3C8K; LIR/MHCI: 1P7Q, 2DYP) [11–19]. (C–E) The
CPXV203/MHCI complex is shown using stick representation
with each interface colored by chain (as in Figure 3A) and element
(C, blue/grey/magenta; O, red; N, dark blue). Side-chains are
shown for all contact residues, and MHCI backbone contacts are
indicated (*). Residues that appear to be involved in putative
hydrogen-bond networks (interface contacts: yellow dots; potential
b5–b6 loop conformation stabilizers: grey dots) are labeled.
Interface views were rotated (relative to Figure 3A) for optimal
viewing: C 10u (y); D 90u (y); E ,90u (x), ,150u (z). (C) CPXV203
contacts the underside of the MHCI peptide-binding platform (a1/
a2) through burial of large hydrophobic residues (I160 and Y161)
immediately following helix-5 (h5). (D) Parallel CPXV203 histidines
from b-sheets I and II coordinate b2m backbone carbonyl oxygens.
The b2m interface MC-MC hydrogen bond is above the shown
view. (E) CPXV203 extensively interacts with conserved MHCI
residues Q226 and E229. CPXV203 H75 and H80 are directly
opposite conserved, acidic MHCI residues D227 and E229. (F,G)
CPXV203 is able to downregulate MHC Ia and Ib molecules but
not mCD1d. WT3 cells were transduced with either vector or
CPXV203-IRES-GFP and then MHCI surface expression was
monitored by flow-cytometry. (F) For H2-M3 expression, cells were
incubated with 20 mM Fr38 (fFMIVIL) peptide from Listeria
monocytogenes at 37uC over night (18 h) before staining by MAb
130, as previously described [20]. CPXV203 downregulated both
the Ia (H-2Kb) and Ib (H2-M3) molecules. Similar studies revealed
that H-2Kk (Ia) and MR1 (Ib) are both susceptible to CPXV203-
mediated downregulation (data not shown). (G) Extension of the
studies to L929-CD1d cells (H-2k) revealed that CPXV203 was not
able to downregulate the Ib molecule CD1d, while the Ia molecule
H-2Dk was efficiently downregulated. SPR and BLI studies at pHER
and pHGolgi also confirmed mCD1d as a null allele (unpublished
data). (H) Comparison of MHCI crystal structures clearly shows
conservation of the a3 loop conformation with the exception of
CD1d. The a3 domains (181–274) of numerous MHCI structures
(murine and human, Ia and Ib) were aligned by combinatorial
extension. A subset of those structures is shown here (PDBs 1VAC,
1P7Q, 3ILP) [18,21,22].
(TIF)
Table S1 SPR analysis of CPXV203/MHCI binding.
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Table S2 Summary of data collection, phasing, and
refinement.
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